Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | XILIO THERAPEUTICS INC XLO | Point72 Asset Management, L.P. | 0 0.000% | -571,429 (Position Closed) | Filing History |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Point72 Asset Management, L.P. | 2,136,940 4.200% | -644,962 (-23.18%) | Filing History |
| 2026-05-15 4:23 pm Sale | 2026-03-31 | 13G | RELAY THERAPEUTICS INC RLAY | Point72 Asset Management, L.P. | 0 0.000% | -13,445,704 (Position Closed) | Filing History |
| 2026-05-15 4:22 pm Sale | 2026-03-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Point72 Asset Management, L.P. | 1,100,964 6.900% | -134,094 (-10.86%) | Filing History |
| 2026-05-15 4:22 pm Sale | 2026-03-31 | 13G | ANAPTYSBIO INC ANAB | Point72 Asset Management, L.P. | 55,303 0.200% | -3,497,252 (-98.44%) | Filing History |
| 2026-05-15 4:21 pm Sale | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Point72 Asset Management, L.P. | 1,903,943 1.300% | -4,823,266 (-71.70%) | Filing History |
| 2026-05-15 4:21 pm Sale | 2026-03-31 | 13G | IMMUNOME INC IMNM | Point72 Asset Management, L.P. | 0 0.000% | -4,887,110 (Position Closed) | Filing History |
| 2026-05-15 4:20 pm Sale | 2026-03-31 | 13G | C4 THERAPEUTICS INC CCCC | Point72 Asset Management, L.P. | 169,096 0.200% | -22,478,551 (-99.25%) | Filing History |
| 2026-05-15 4:20 pm Purchase | 2026-03-31 | 13G | DAMORA THERAPEUTICS, INC DMRA | Point72 Asset Management, L.P. | 1,193,708 2.000% | 1,093,707 (+1093.70%) | Filing History |
| 2026-05-15 4:19 pm Sale | 2026-03-31 | 13G | IBIO INC PAR $0.001 IBIO | Point72 Asset Management, L.P. | 0 0.000% | -14,289,118 (Position Closed) | Filing History |
| 2026-05-15 4:19 pm Purchase | 2026-03-31 | 13G | CENTURY THERAPEUTICS INC IPSC | Point72 Asset Management, L.P. | 5,964,678 3.300% | 3,115 (+0.05%) | Filing History |
| 2026-05-15 4:18 pm Sale | 2026-03-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Point72 Asset Management, L.P. | 1,985,547 2.300% | -2,342,405 (-54.12%) | Filing History |
| 2026-05-15 4:17 pm Sale | 2026-03-31 | 13G | PALATIN TECHNOLOGIES INC N PTN | Point72 Asset Management, L.P. | 8,600 0.500% | -2,298,400 (-99.63%) | Filing History |
| 2026-05-15 4:17 pm Sale | 2026-03-31 | 13G | ORIC PHARMACEUTICALS INC ORIC | Point72 Asset Management, L.P. | 0 0.000% | -4,401,659 (Position Closed) | Filing History |
| 2026-05-15 4:16 pm Sale | 2026-03-31 | 13G | BLACK ROCK COFFEE BAR INC BRCB | Point72 Asset Management, L.P. | 755,707 4.300% | -192,708 (-20.32%) | Filing History |
| 2026-05-15 4:15 pm Sale | 2026-03-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Point72 Asset Management, L.P. | 65,933 0.200% | -1,503,376 (-95.80%) | Filing History |
| 2026-05-15 4:14 pm Sale | 2026-03-31 | 13G | LIONSGATE STUDIOS CORP COM LION | Point72 Asset Management, L.P. | 6,844,626 2.400% | -7,823,587 (-53.34%) | Filing History |
| 2026-05-15 4:13 pm Sale | 2026-03-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Point72 Asset Management, L.P. | 0 0.000% | -17,050,384 (Position Closed) | Filing History |
| 2026-05-15 4:13 pm Purchase | 2026-03-31 | 13G | ANGIODYNAMICS INC ANGO | Point72 Asset Management, L.P. | 3,181,829 7.700% | 622,440 (+24.32%) | Filing History |
| 2026-05-15 4:11 pm Sale | 2026-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management, L.P. | 1,170,865 3.700% | -1,653,410 (-58.54%) | Filing History |